140 related articles for article (PubMed ID: 3315389)
1. Cardiovascular effects of verapamil in essential hypertension.
Städler P; Leonardi L; Riesen W; Ziegler W; Marone C; Beretta-Piccoli C
Clin Pharmacol Ther; 1987 Nov; 42(5):485-92. PubMed ID: 3315389
[TBL] [Abstract][Full Text] [Related]
2. Alpha 1-adrenergic blockade and cardiovascular pressor responses in essential hypertension.
Beretta-Piccoli C; Ferrier C; Weidmann P
Hypertension; 1986 May; 8(5):407-14. PubMed ID: 2870984
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and metabolic profile during intervention with urapidil in humans.
Gerber A; Weidmann P; Marone C; Uehlinger D; Riesen W
Hypertension; 1985; 7(6 Pt 1):963-71. PubMed ID: 3908316
[TBL] [Abstract][Full Text] [Related]
4. Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjects.
Boehringer K; Beretta-Piccoli C; Weidmann P; Meier A; Ziegler W
Hypertension; 1982; 4(5):697-702. PubMed ID: 7049922
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular pressor reactivity after chronic converting enzyme inhibition.
Bernasconi M; Marone C; Beretta-Piccoli C; Lepori G; Shaw S; Weidmann P
Am J Hypertens; 1991 Apr; 4(4 Pt 1):348-55. PubMed ID: 1829371
[TBL] [Abstract][Full Text] [Related]
6. Pressor factors and responsiveness in hypertension accompanying diabetes mellitus.
Weidmann P; Beretta-Piccoli C; Trost BN
Hypertension; 1985; 7(6 Pt 2):II33-42. PubMed ID: 3908320
[TBL] [Abstract][Full Text] [Related]
7. Body sodium-blood volume state, aldosterone, and cardiovascular responsiveness after calcium entry blockade with nifedipine.
Marone C; Luisoli S; Bomio F; Beretta-Piccoli C; Bianchetti MG; Weidmann P
Kidney Int; 1985 Oct; 28(4):658-65. PubMed ID: 3910913
[TBL] [Abstract][Full Text] [Related]
8. Pressor factors and cardiovascular pressor responsiveness in borderline hypertension.
Meier A; Weidmann P; Grimm M; Keusch G; Glück Z; Minder I; Ziegler WH
Hypertension; 1981; 3(3):367-72. PubMed ID: 7019068
[TBL] [Abstract][Full Text] [Related]
9. Similarities and differences in the antihypertensive effect of two calcium antagonist drugs, verapamil and nifedipine.
Agabiti-Rosei E; Muiesan ML; Romanelli G; Castellano M; Beschi M; Corea L; Muiesan G
J Am Coll Cardiol; 1986 Apr; 7(4):916-24. PubMed ID: 3514729
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive mechanism of diuretic treatment with chlorthalidone. Complementary roles of sympathetic axis and sodium.
Weidmann P; Beretta-Piccoli C; Meier A; Keusch G; Glück Z; Ziegler WH
Kidney Int; 1983 Feb; 23(2):320-6. PubMed ID: 6341684
[TBL] [Abstract][Full Text] [Related]
11. Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonists.
Muiesan G; Agabiti-Rosei E; Romanelli G; Muiesan ML; Castellano M; Beschi M
Am J Cardiol; 1986 Feb; 57(7):44D-49D. PubMed ID: 3006466
[TBL] [Abstract][Full Text] [Related]
12. Pressor factors and cardiovascular pressor responsiveness after short-term antihypertensive therapy with the calcium antagonist nifedipine alone or combined with a diuretic.
Marone C; Luisoli S; Bomio F; Beretta-Piccoli C; Bianchetti MG; Weidmann P
J Hypertens Suppl; 1984 Dec; 2(3):S449-52. PubMed ID: 6599697
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive mechanism of amlodipine in essential hypertension: role of pressor reactivity to norepinephrine and angiotensin II.
Donati L; Bühler FR; Beretta-Piccoli C; Kusch F; Heinen G
Clin Pharmacol Ther; 1992 Jul; 52(1):50-9. PubMed ID: 1385565
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular counterregulation during sympathetic inhibition in normal subjects and patients with mild hypertension.
Weidmann P; Beretta-Piccoli C; Link L; Bianchetti MG; Boehringer K; Morton JJ
Hypertension; 1983; 5(6):873-80. PubMed ID: 6360870
[TBL] [Abstract][Full Text] [Related]
15. Sodium and responses to infused noradrenaline and angiotensin II in subjects predisposed to hypertension.
Pusterla C; Beretta-Piccoli C; Städler P; Weidmann P; Shaw S
J Hum Hypertens; 1988 Mar; 1(4):267-76. PubMed ID: 3065505
[TBL] [Abstract][Full Text] [Related]
16. Modulation of noradrenergic but not angiotensinergic blood pressure control by beta-blockade with carteolol.
Saxenhofer H; Morger D; Weidmann P; Ferrier C; Shaw SG
J Hypertens; 1991 Nov; 9(11):1049-56. PubMed ID: 1661763
[TBL] [Abstract][Full Text] [Related]
17. Hypotensive action of calcium antagonists as related to plasma noradrenaline and reactivity to noradrenaline.
Schwietzer G; Distler A; Reeck S; Thiede HM; Philipp T
J Hypertens Suppl; 1983 Dec; 1(2):102-4. PubMed ID: 6400109
[TBL] [Abstract][Full Text] [Related]
18. Hypertensive dysregulation and its modification by calcium channel blockade in nonoliguric renal failure.
Weidmann P; Schohn D; Gnädinger MP; Bürgisser E; Ferrier C; Jahn H
Am J Nephrol; 1989; 9(4):269-78. PubMed ID: 2683789
[TBL] [Abstract][Full Text] [Related]
19. Circulatory volume in essential hypertension. Relationships with age, blood pressure, exchangeable sodium, renin, aldosterone and catecholamines.
Beretta-Piccoli C; Weidmann P
Miner Electrolyte Metab; 1984; 10(5):292-300. PubMed ID: 6387428
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure regulation on low and high sodium diets in normotensive members of normotensive or hypertensive families.
Pusterla C; Beretta-Piccoli C; Städler P; Weidmann P; Favre L; Vallotton M
J Hypertens Suppl; 1986 Dec; 4(6):S310-3. PubMed ID: 3475419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
